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Abstract
FABRICATION AND CHARACTERIZATION OF SOL-GEL BASED
NANOPARTICLES FOR DRUG DELIVERY
By
Reeta Yadav

Adviser: Professor Uri Samuni
Nanogels are cross linked polymeric sol-gel based nanoparticles that offer an interior network for
incorporation and protection of biomolecules, exhibiting unique advantages for polymer based
delivery systems. We have successfully synthesized stable sol-gel nanoparticles by means of [a]
silicification reactions using cationic peptides like polylysine as gelating agents, and [b]
lyophilization of sol-gels. Macromolecules such as Hemoglobin and Glucose Oxidase and small
molecules such as Sodium Nitroprusside (SNP) and antibiotics were encapsulated within the
nanogels. We have used transmission electron microscopy, dynamic light scattering, zeta
potential analysis, and spectroscopy to perform a physicochemical characterization of the
nanogels resulting from the two approaches. Our studies have indicated that the nanogel
encapsulated proteins and small molecules remain intact, stable and functional.
A Hydrogen Peroxide (H2O2) and Nitric Oxide (NO) generating drug carrier was
synthesized using these nanogels and the effect of generation of H2O2 from Glucose Oxidase
encapsulated nanogels and NO from SNP encapsulated nanogels was tested on E.coli. The
results show that the nanoparticles exert antimicrobial activity against E.Coli, in addition NO
generating nanogels potentiated H2O2 generating nanogels induced killing. These data suggest
that these NO and H2O2 releasing nanogels have the potential to serve as a novel class of
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antimicrobials for the treatment of multidrug resistant bacteria. The unique properties of these
protein/drug incorporated nanogels raise the prospect of fine tailoring to specific applications
such as drug delivery and bio imaging.
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CHAPTER 1
INTRODUCTION
Rapid developments in the pharmaceutical drug discovery are resulting in an increasing
number of novel therapeutic drugs for the treatment of a variety of diseases. However, the main
problems associated with systemic drug administration for most diseases still remain, which
includes the even bio distribution of administered pharmaceuticals throughout the body, the lack
of drug specific affinity toward a pathological site, nonspecific toxicity and other side effects
resulting from high doses. There has been a rapid growth of interest in the use of nanotechnology
and nanoparticles. Nanoparticle based drug delivery and drug targeting systems aim to minimize
drug degradation and inactivation upon administration, prevent undesirable side effects and
increase drug bioavailability. The use of nanoparticles as pharmaceutical carriers to enhance the
in vivo efficiency of many drugs has been well established over the past decade, in both
pharmaceutical research and the clinical setting [1].
The key parameters in the design and formulation of carrier systems are preparation and
entrapment method, size, stability and degradation characteristics of the bioactive-carrier
complex as well as release kinetics of the entrapped material. In general biodegradable and bio
absorbable carriers are preferred so that they would degrade inside the body by hydrolysis or by
enzymatic reactions, without producing any toxic products. Over the years numerous techniques
have been developed for the preparation of the carrier systems and entrapment of bioactives to
these carriers [2]. However, most of these methods are not suitable for entrapment of sensitive
substances because of their exposure either to mechanical stresses (e.g. high-shear
homogenization, sonication, high pressures), potentially harmful chemicals (e.g. volatile organic
solvents, detergents), or low/high values of pH during the preparation. Many of these preparation
techniques require the application of harmful volatile solvents (e.g. chloroform, ether, methanol,
1

acetone) to solubilize the ingredients. Such solvents not only affect the chemical structure of the
entrapped substance but also may remain in the final formulation and contribute to toxicity and
influence the stability of the carrier systems. In general, residual organic solvents have no
therapeutic benefits, but may be hazardous to human and animal health as well as the
environment [2-4]. In addition to the above mentioned disadvantages, use of volatile organic
solvents necessitates performance of two further steps in the synthesis of the carrier systems: i)
removal of these solvents, and ii) assessment of the level of residual organic solvents in the
formulations.
Nanogels are a recent addition to the list of known physical nanocarriers, which have
found applications as drug delivery systems. The term ‘nanogels’ defines dispersions of hydrogel
particles formed by physically or chemically cross-linked polymer networks of nanometric
dimensions. Hydrophilic particles with high dispersion stability can be produced by loading
biological agents and drugs into nanogels via a spontaneous process including interactions
between the agent and the polymer matrix. Studies have shown that nanogels were able to
physically protect biological molecules from degradation in vivo and have been investigated for
different types of active molecules, ranging from small drugs to bio macromolecules [3].
Nanogels show excellent potential as drug delivery carriers because of their high loading
capacity, high stability and responsiveness to environmental factors, such as ionic strength, pH,
and temperature that are unprecedented for common pharmaceutical nanocarriers [1].
Many approaches have been used for the preparation of nanogels, most of which can be
divided into 1) physical self-assembly of interactive polymers; 2) polymerization of monomers in
a homogeneous phase or in a micro or nanoscale heterogeneous environment; 3) crosslinking of
preformed polymers; and 4) template assisted nanofabrication of nanogel particles [3]. A method
2

of great interest is the sol-gel process, which is a wet-chemical technique widely used in the
fields of materials science and ceramic engineering. Sol-gel materials are prepared by generation
of colloidal suspensions (“sols”) which are subsequently converted to viscous gels and thence to
solid materials. Typical precursors for this gel are metal alkoxides, which undergo various forms
of hydrolysis and polycondensation reactions. Lately there has been considerable increase in solgel synthesized materials for biological applications as they offer many advantages compared to
other conventional methods. The temperatures required for most stages are close to room
temperature thus minimizing any thermal degradation of both the material itself and any
entrapped species, leading to high purity and higher yield. Due to the mild temperature and pH
conditions used, pH sensitive organic species (e.g. Dyes) and even biological species including
enzymes and whole cells can be entrapped and still retain their functions. Another reason why
this technique is valuable is because appropriate chemical modification of the precursors, can
give control over the rates of hydrolysis and condensation and thus change colloid particle size
and the pore size, porosity and pore wall chemistry of the final material. Also it is possible to do
covalent attachment of organic and biological species to porous silicate glass structures using
functionalized precursors [4,5]. All these properties of sol-gel are very useful for an optimal
nanotherapy because it is important that the therapeutic molecule is protected from degradation
and reach its targeted intracellular locations without interactions with non-target cells.
Interestingly, certain organisms such as diatoms (Figure 1) have developed mechanisms
for generating intricate structures based on silica. This formation of in vivo silica based structures
has been studied in depth and it is known that biosilicification occurs under mild
physicochemical conditions. A recent work published in Science by Kroger et al.[6] has shown
that silica precipitating proteins (silaffin proteins) such as R5 (Figure 2) from the diatom
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Cylindrotheca fusiformis can catalyze the precipitation of silica within seconds when added to a
solution of silicic acid with a resulting material of fused spherical silica particles with an average
diameter of 500nm [7-9]. Entrapment and enzyme immobilization studies done with
butyrylcholinesterase and catalase have revealed that biosilica not only provides an excellent
immobilization and matrix support but also retains 90% of the enzyme activity [8].

a

b

c

Figure 1. Diatoms, a. Coscinodiscus; b. Stephanodiscus; c. Lyrella hennedyi. Diatoms develop
intricate structures based on silica. [Mann, David G. 2010. Diatoms. Version 07 February 2010.
http://tolweb.org/Diatoms/21810/2010.02.07 in The Tree of Life Web Project, http://tolweb.org/]

Thus biosilicification reactions catalyzed by silica precipitating peptides can be used as a
new route for the entrapment of an exogenously added enzyme or drug in the silica matrix. Use
of Poly-L-Lysine (PLL) (Figure 2) which is also a silica precipitating peptide has the additional
advantages of utilizing the chemical properties of lysine for functionalization of the nanoparticles
and selective binding of bioactive agents. Naik et al. have shown that the formation of biosilica
structures can be controlled by manipulation of the physical reaction environment; they showed
several silica nanomorphologies ranging from common spheres to highly organized and complex
fibrillar morphologies, catalyzed by the R5 peptide under varied conditions [9].

4

Figure 2. R5 Peptide (Top) and structure of Poly-L-Lysine (bottom)

THE SOL-GEL PROCESS
The term sol-gel refers to a process in which solid nanoparticles dispersed in a liquid (a sol)
agglomerate together to form a continuous three-dimensional network extending throughout the
liquid (a gel). The sol-gel process is a method for producing solid materials from small
molecules. The method is used for the fabrication of metal oxides, especially the oxides of
silicon and titanium. Typical precursors are metal alkoxides and metal chlorides, which undergo
hydrolysis and polycondensation reactions to form a colloid. The basic structure or morphology
of the solid phase can range anywhere from discrete colloidal particles to continuous chain-like
polymer networks [5].
In either case (discrete particles or continuous polymer network) the sol leads to the formation of
an inorganic network containing a liquid phase (gel). Formation of a metal oxide involves
connecting the metal centers with oxo (M-O-M) or hydroxo (M-OH-M) bridges, therefore
generating metal-oxo or metal-hydroxo polymers in solution. A drying process serves to remove
the liquid phase from the gel, yielding a micro-porous amorphous glass.
A well-studied alkoxide is tetramethyl orthosilicate (TMOS). The chemical formula for TMOS is
given by Si(OCH3)4, or Si(OR)4, where the alkyl group R = CH3. Alkoxides are ideal chemical
5

precursors for sol-gel synthesis because they react readily with water. In a hydrolysis reaction, a
hydroxyl ion becomes attached to the silicon atom as follows:
Si(OR)4 + H2O → HO-Si(OR)3 + R-OH

Depending on the amount of water and catalyst present, hydrolysis may proceed to completion to
silica:
Si(OR)4 + 2 H2O → SiO2 + 4 R-OH
Complete hydrolysis requires a significant excess of water and catalysts such as acetic acid or
hydrochloric acid. Intermediate species include [(OR)2–Si-(OH)2 ] or [(OR)3 –Si-(OH)], resulting
from partial hydrolysis reactions. Two partially hydrolyzed monomers would result in early
intermediates linked via a siloxane [Si–O–Si] bond:
(OR)3 –Si-OH + HO–Si-(OR)3 → [(OR)3Si–O–Si(OR)3] + H-O-H
or
(OR)3 –Si-OR + HO–Si-(OR)3 → [(OR)3Si–O–Si(OR)3] + R-OH
Thus, polymerization is associated with the formation of a 1, 2, or 3- dimensional network of
siloxane [Si–O–Si] bonds accompanied by the production of H-O-H and R-O-H species (Figure
3).
Condensation liberates a small molecule, such as water or alcohol. This type of reaction can
continue to build larger and larger silicon-containing molecules by the process of
polymerization. The hydrolysis and polycondensation reactions initiate at numerous sites within
6

the TMOS + H2O solution as mixing occurs. When sufficient interconnected Si-O-Si bonds are
formed in a region, they cooperatively form colloidal (submicrometer) particles or a sol. The size
of the sol particles and the cross-linking within the particles (i.e., density) depend upon the pH
and R ratio (R = [H2O]/[Si(OR)4]) Polymerization of silicon alkoxide, for instance, can lead to
complex branching of the polymer, because a fully hydrolyzed monomer Si(OH)4 is
tetrafunctional. Alternatively, under certain conditions such as low water concentration fewer
than 4 of the OR or OH groups (ligands) will be capable of condensation, so relatively little
branching will occur. The mechanisms of hydrolysis and condensation, and the factors that direct
the structure toward linear or branched structures are the most critical issues of sol-gel science
and technology. This reaction is favored in both basic and acidic conditions [10].

TMOS
H2O

O
H 2O

Si

O

O
O
H2O

H2O
HO OH

OH
Si
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HO
HO

OH
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Si

Si
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Si
OH

Si
O

Si

O

O

O

OH

Si

OH
O
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SOL-GEL MATRIX

Figure 3. Simplified representation of condensation of TMOS
in the sol-gel process. (Top) Tetra methyl ortho silicate
monomer and (bottom) the sol-gel matrix
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Since the sol is a low-viscosity liquid, it can be cast into a mold. The mold must be selected to
avoid adhesion of the gel. With time the colloidal particles and condensed silica species link
together to become a three-dimensional network. The physical characteristics of the gel network
depend greatly upon the size of particles and extent of cross-linking prior to gelation. At
gelation, the viscosity increases sharply, and a solid object results in the shape of the mold.
Aging of a gel involves maintaining the cast object for a period of time, hours to days,
completely immersed in liquid. During aging, polycondensation continues along with localized
solution and re-precipitation of the gel network, which increases the thickness of interparticle
necks and decreases the porosity. The strength of the gel thereby increases with aging. An aged
gel must develop sufficient strength to resist cracking during drying [4,5,10].

Although several studies have demonstrated the synthesis of silicate particles using
synthetic peptides and polyamines, there is not much work done on physicochemical
characterization and optimization of these particles which is much needed before they can be
used for therapeutic drug delivery. Our aim with our experiments was to extend these studies and
find optimum synthetic conditions to produce stable sol-gel based nanoparticles which can be
fabricated and characterized for drug delivery and a wide number of other applications. We
report here use of two different sol-gel based techniques to synthesize nanogels (i) Sol-gel
lyophilization technique and (ii) a biomimetic polycationic peptide technique.

We also

performed a physicochemical characterization of the resulting nanogels from the two techniques
and report future applications.
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CHAPTER 2
SYNTHESIS OF SOL-GEL BASED NANOPARTICLESDIFFERENT APPROACHES
Two different approaches were used for synthesis of sol-gel based nanoparticles, the
Polycationic peptide protocol and the Lyophilization protocol. Both approaches start out with
the hydrolysis and condensation of a common precursor alkoxide, Tetramethyl ortho silicate
(TMOS) (Figure 4). Once the colloidal solution (sol) of TMOS is formed, (i) nanoparticles can
be precipitated out of the sol using polycationic peptides such as Poly-L-Lysine (PLL) or (ii) the
sol can undergo further condensation and polymerization reactions leading to continuous glass
like gels which can be lyophilized to yield sol-gel based nanogels.
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Metal
Alkoxide
Solution
Hydrolysis
Polymerization

SOL

Precipitation
Gelling

UNIFORM PARTICLES

WET GEL/SOL-GEL
Drying
Lyophilization

NANOPARTICLES
Figure 4. General Scheme for synthesis of sol-gel based nanoparticles
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Polycationic peptide protocol
“The polycationic peptide protocol” is based on the use of polycationic peptides such as
Polylysine for precipitating out sol-gel nanoparticles from a colloidal solution of TMOS (Figure
5). This protocol is a modified protocol based on methods used by Naik et al. (2004) [8].
The following standard procedure was used for synthesis of all nanogels using polypeptides:
TMOS (sigma, >99 % purity) was hydrolyzed by adding 1mM HCl (1:5 ratio) and sonicated for
30 minutes. Then 50 mM of Potassium Phosphate buffer pH 7 with the desired protein or
molecule was mixed with the hydrolyzed TMOS solution. The mixture was left standing for 5
minutes at room temperature. 1ml deionized water was added to terminate the reaction. The
solution was washed by centrifugation 3 times. After the final wash the particles were resuspended in phosphate buffer. To make control nanogels no protein is added to the buffer.
When polylysine is used as the silica precipitating agent in the polycationic protocol then it
would be referred to as “Polylysine protocol”.

11

Phosphate Buffer + Protein/Drug
+Cationic peptide +TMOS solution.

Reaction
time 5 min

add water

centrifuge

wash

Resuspended
in buffer

Nanogels

Figure 5. Synthesis of nanogels using Polycationic peptide protocol.
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Lyophilization Protocol
“The lyophilized protocol” involves encapsulating the desired molecules inside a polymeric solgel matrix followed by a stage where the matrix is dried and finally lyophilizing the dried gel
matrix (Figure 6).
The following standard procedure was used for synthesis of all nanogels using lyophilization:

TMOS was hydrolyzed by adding 2mM HCl (2:1 ratio) and sonicated for 30 minutes.

Desired concentration of protein or small molecule was added to 50mM phosphate buffer pH 7.
The buffer/protein mixture was added to hydrolyzed TMOS (1:1 ratio) and mixed and casted in
desired container. The solution formed uniform gels in 30 seconds to 1 minute. The casted gel
was washed with buffer 3 times to remove side products from surface of the gel. For control gels
no protein was incorporated in the buffer.

To make nanogels, the sol-gel films were slightly crushed using a spatula and dried at room
temperature for 12 hours and lyophilized for 5 hours (LABCONCO, freezone).

13

50mM Phosphate
Buffer pH 7 +
Drug/Protein

TMOS solution
(2mM HCl + TMOS)

Lyophilization
Sol-gel film

Nanogels

Figure 6. Synthesis of nanogels using Lyophilization protocol.
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CHAPTER 3
PHYSICOCHEMICAL CHARACTERIZATION OF NANOGELS
The application of any nanocarrier platform requires high degree of control over their
physicochemical properties. We performed systematic physicochemical studies including size
distribution and aggregation, protein stability, protein/sol-gel interactions and protein release
from sol-gel. The synthesis of particles was studied by varying different conditions like
temperature changes, varying buffer and salt concentrations, different chain lengths of cationic
polypeptides. Size characterization, particle morphology, size distribution and aggregation was
studied by Transmission Electron Microscopy (TEM) combined with Dynamic Light Scattering
(DLS). Protein stability, protein sol-gel interaction and release were studied using UV/Visible
absorption spectroscopy. Characterization of surface properties of nanoparticulate carriers is
complicated by charges of the different components of the nanospheres, the composition of the
dispersion medium, and the extent of binding of biomolecule onto the nanoparticle. Thus we use
Zeta potential measurements to study the surface properties and formulation stability of the
particles.

15

EXPERIMENTAL PROCEDURES
Dynamic Light Scattering (DLS) and Zeta Potential Analysis
DLS measurements were performed on a 90 plus particle size analyzer (Brookhaven Instruments
Corporation) employing a 90° scattering angle and a 35 mW incident laser (658 nm). Small
amounts of nanogels (1-2mg) were suspended in deionized water and sonicated for 15 minutes
before taking measurements. The reported diameter is the average of 5 runs for each sample.
Zeta Potential measurements were done by adding small amount (1-2mg) of nanogels in 1mM
KCl solution and sonication for 15 minutes. (Brookhaven Instruments Inc. Zeta Plus).
Transmission Electron Microscope (TEM) Studies
Dilute samples used for DLS measurements were mixed in a 1:1 ratio with 1% uranyl acetate,
sonicated for 10 minutes. Then 5ul was put on a carbon film coated copper grid, 300 mesh
(electron microscopy sciences, Hatfield, PA) and the excess solution was removed immediately
using absorbent paper. The grids were dried overnight and viewed under the transmission
electron microscope (JEOL, model JEM-1200 EX). Images were taken with a SIA–L3C CCD
camera (Scientific Instruments and Applications, Inc.) using the software Maxim DL5
(Diffraction Limited, Ottawa, Canada).
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SIZE AND ZETA POTENTIAL ANALYSIS OF NANOGELS USING DYNAMIC LIGHT
SCATTERING
DLS studies have indicated that different populations are present in nanogel solutions prepared
using the Lyophilization method. The particle diameter ranges from 80 to 300nm.
For particles prepared using the polylysine protocol the particles range in size from 300 to
500nm with multimodal population.
These measurements correlate with TEM images (Figure 7 and 8) for both kinds of nanogels
showing multiple populations.
Zeta potential (a measure of colloidal stability) measurements indicate that the lyophilized
nanogels have a negative charge with zeta potential of -30mV, whereas PLL precipitated
nanogels have a lower colloidal stability with a zeta potential of -8mV.
It was found that protein or the surfactant Polyethylene Glycol (PEG) (PEG is a steric stabililizer
with various advantages discussed in Chapter 4) incorporation inside nanogels during the
gelation step has no effect on zeta potential, indicating that incorporation of molecules inside the
nanogel matrix does not affect its colloidal properties.

17

SIZE ANALYSIS OF NANOGELS USING TRANSMISSION ELECTRON MICROSCOPE

0.5 µm

Figure 7. TEM micrograph of control Nanogels synthesized using the
Lyophilization protocol. The average nanoparticle size range is 50100 nm, Scale Bar: 0.5 µm.

0.5 µm

Figure 8. TEM micrograph of control nanogels using the Polylysine
protocol). The average nanoparticle size range is 100-300nm, Scale Bar: 0.5
µm.

18

Studies from Transmission Electron Microscope (Figure 7 and 8) suggest that the lyophilized
nanogels are uniformly dispersed circular particles with a size range of 10nm to 200nm most of
the particles being 60nm. Presence or absence of encapsulated proteins or molecules inside the
nanogels did not have a considerable effect on the nanogel’s size and distribution as shown in
further chapters. The polylysine precipitated nanogels have a slightly larger size of 100 to 300
nm.
Characterization of Nanogels under different conditions.
The size dependence on Phosphate concentration in the range 3-200 mM was tested
and there was no correlation with the resultant nanogel size (Table 1). Slight differences seen in
the particle size are attributed to error in the instrument and changes due to solution stability.

Table 1. Size of nanogels dispersed in phosphate buffers of different
concentrations as obtained from Dynamic Light scattering instrument.

Phosphate Buffer Concentration

Effective Diameter (nm)

3mM

143

10mM

138

30mM

207

100 mM

240

200 mM

210
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Tests utilizing Potassium Chloride, Citrate buffer, TRIS- HCl as buffers for suspension of
nanogels resulted in similar results and showed no effect on particle size of the particles.
The solubility of nanogels was also probed under different pH conditions (pH range: 5-7.5) and it
was seen that there was no marked effect on the stability and size distribution of the nanogels
when exposed to these pH conditions. Exposure to highly acidic conditions (pH 2) had no effect
whereas exposure to highly alkaline conditions (pH 10-12), show smaller sizes of nanogels. This
effect is discussed in more detail in later sections of this chapter.
As discussed earlier the nanogels synthesized from the Polylysine protocol have a tendency to
aggregate and are not colloidally stable for long periods of time (as compared to the nanogels
produced from Lyophilization protocol). The stability and size of these particles were studied
using the surfactant Polyethylene Glycol (PEG) to decrease aggregation and improve stability.
Addition of increasing concentrations of PEG-400 decreased the size of the particles as tested by
the DLS, showing low aggregation (Table 2). The Zeta Potential also became increasingly
negative for the nanoparticles showing higher colloidal stability due to low aggregation (Table
3).

Table 2. The change in effective diameter of the nanoparticles
with increasing amounts of PEG-400 added into suspending buffer.
The effective diameter of the nanoparticles decreases as the PEG
content increases.

[PEG-400] (%v/v)
0
1.25
2.5
3.75
5

Effective diameter of ngs (nm)
800
380
500
450
390
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Table 3. The change in zeta potential of nanogels with increasing
amounts of PEG-400 added into the suspending buffer . The zeta potential
of the nanoparticles becomes increasingly negative as higher amounts of PEG
added suggesting greater colloidal stability.

[PEG-400] (% v/v)
0
0.25
0.5
0.75
1

Zeta Potential of ngs (mV)
-8
-16
-13
-19
-27

RELEASE STUDIES ON ENCAPSULATED MOLECULES –Polylysine
protocol
Release of encapsulated molecules was tested using UV/Visible spectroscopy. The protein Met Myoglobin (Met-Mb) was incorporated inside the nanogels synthesized using the polylysine
protocol (encapsulation confirmed by UV spectra showing characteristic absorbance peak at 407
nm) (Figure 9) and the release of protein from the nanogels was tested by suspending the
particles in pH 7 phosphate buffer and spinning down the particles at different time intervals to
measure the Met-Mb characteristic O.D at 407nm in the supernatant (Figure 10).
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Myoglobin in solution

Absorbance

1.4
1.2
1.0
0.8
0.6
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Myoglobin in nanogels

1.6

Absorbance

350

1.5
1.4
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350

400

Wavelength (nm)
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500

Figure 9. UV/Visible spectra of Met-Mb in solution and Met-Mb
encapsulated nanogels. Characteristic peak of Met-Mb at 407nm
suggests the encapsulation of the protein inside nanogels.
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Mb Leaking (30 minute intervals)

0.25

Initial Mb in nanogel
Interval 1
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Interval 3
Interval 4
Interval 5
Interval 6
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after interval 1)
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a
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% Release of Mb
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Figure 10. a. UV/Vis spectra of Met Mb released into bathing buffer at
different time intervals. b. Release of incorporated Met-Myoglobin from
nanogels (synthesized by Polylysine protocol). O.D at 407nm was used to
determine the % release of Mb from the nanogels.

About 40% of the protein is released within 5 minutes. The remaining is released through a slow
and steady rate. The release of the protein from polylysine protocol nanogels is spontaneous.
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Once synthesized the encapsulated protein readily diffuses out of the porous matrix.
Encapsulation of other filling molecules such as surfactants (PEG, cellulose, other polymers)
inside the matrix may be able to provide more control over release properties of these peptide
precipitated nanogels for application where the molecules are required to stay inside the nanogels
for a longer period of time.
RELEASE STUDIES ON ENCAPSLATED MOLECULES (Sol- gel films)
Protein release studies were carried out on sol-gel films to evaluate release properties of the solgel matrix and gain insight into similar properties of synthesized nanoparticles. The studies were
done on Hemoglobin (Hb) (Hb is discussed in detail in Chapter 5) encapsulated nanogels using
UV/Visible spectroscopy. These studies were performed under different pH conditions. The
effect of concentration and temperature was also studied for possible changes in release patterns.
Sol-gel films containing Hemoglobin were casted on sides of standard cuvettes using our
standard sol-gel procedure and bathed in phosphate buffers with varying pH’s (pH 2-12) , ionic
concentrations (5mM, 50mM, 200mM, 500mM) and temperatures (10oC, 23oC, 35oC). The
bathing buffer was separated at different time intervals and probed using UV/Visible spectra to
test release of protein into the buffer detected by characteristic Hb absorbance at 405nm. The
measured absorbance was correlated to % protein released over time.
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Results
There is no evidence for Hb release from the sol-gel matrix under buffer conditions of pH 2-8,
indicating it remains trapped within the matrix. However there is substantial release under
alkaline conditions (Figure 11). About 60% of the protein is released from the sol-gel film in 2
hours when exposed to pH 12. (Table 4)

Table 4. Release of Hb from sol-gel films under different pH conditions. Release of Hb from sol-gel films was
measured by taking O.D of bathing buffer at 405nm over different time intervals and correlated to % release.

pH

Hemoglobin release

2
4.5
5.5

NO RELEASE

6
7
8
10

0.6 % released in 2 hours

12

Substantial release, about 0.5 % /min. Approx. 60% released in 2
hours.
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0.5

Hemoglobin Release from Solgel (at different pH conditions)
pH 7 control
pH 7 after 24hrs
pH 12.4 control
pH12.4 after 24hrs
pH 7 after 48 hrs
pH 12.4 after 48 hrs

Absorbance (nm)

0.4

0.3

0.2

0.1

200

300

400

500
Wavelength (nm)

600

700

800

Figure 11. UV/Vis spectra for release of Hb at pH 7 and pH 12.4. Release of Hb from sol-gel films
was determined by measuring the OD of bathing buffer at 405nm over different time intervals and
correlated to % release.

Similar release experiments were performed with Myoglobin encapsulated sol-gel films and it
was seen that there is no release of Myogobin from sol-gel films at pH 7 but substantial release
after exposure to pH 12.4 for 1.5 hours (Figure 12).
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0.5
pH 7 initial
pH 12.4 initial
pH 7 after 25 min
pH12.4 after 25 min
pH7 after 1.5 hours
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Figure 12. UV/Vis spectra for release of Mb from sol-gel films. Release of Mb from
sol-gel films was determined by measuring the OD of bathing buffer at 407nm over
different time intervals.
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Release profiles of proteins were tested at various conditions of temperatures and ionic strength
of buffers, and long term storage. The concentration of bathing buffer (5mM-500mM) and
temperature (4oC-60oC) had negligible effect on immediate release of Hb and Mb proteins. When
exposed to very high temperatures for extended periods of time there was only about 0.5%
release of Hb and about 2% release of Mb from the sol-gel films. Short term storage (1 day to 1
week) or Long Term Storage of sol-gels (1 week to 2 months) does not show any release of
encapsulated proteins into the buffer.
The release of a small molecule, the potential anticancer drug Distamycin A ( also discussed in
Chapter 6) from sol-gel films was tested at pH 7 and pH 12 (Figure 13). Distamycin A was
encapsulated inside sol-gel films using the standard protocol for making sol-gel films and release
into bathing buffer was tested by UV/Vis spectroscopy to see characteristic peak at 303nm. It is
seen that the release of small molecules is also higher at alkaline conditions.

Time (hours)

Release of Distamycin from Sol-gel
24

57

1

48

0.4

34
0

20

40

74

55

pH 12.4
pH 7

48
60

80

Percentage Release
Figure 13. Release of small molecule Distamycin A from solgel films. Release of Distamycin A was determined by
measuring O.D of bathing buffer at 303nm. The O.D was
correlated to % release over time.
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The sol-gel matrix seems to degrade at alkaline pH conditions. This conclusion is supported by
the observation that sol-gel films tend to thin down after exposure to basic buffer and is
completely degraded/diminished after bathing in this buffer for 2-3 days. Moreover when
nanogels were synthesized from these films and suspended in pH 12 buffer, the effective
diameter measured using DLS decreased over time and the diameter was close to zero in a period
of 2 hours (Table 5). Similar degradation of particles was noticed in nanogels produced from
both Lyophilization and Polylysine protocols.

Table 5. Effective diameters of nanogels exposed to basic conditions over a function of time.
The size of the nanogels decreases with increasing exposure time to pH 12 phosphate buffer.

Time (min) of exposure of
nanogels to pH 12 buffer
0
60
120
140

Effective Diameter (nm)
360
18
8
0

The effect of concentration (5mM-500mM) and temperature (10oC-35oC) was found to have
negligible difference on release patterns in a period of 2 hours. Higher temperature of about 52oC
does not show any release of encapsulated protein immediately, however continuous exposure
for about 60 minutes to high temperature shows only 0.5% release of Hb and approximately 2%
release of Mb from sol-gel films. A slightly higher % release of Mb is expected in comparison to
Hb (over extended periods of time) because of the comparatively smaller size of Mb.
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Conclusions
After analysis of the nanogels resulting from two different approaches (Polylysine and
Lyophilization) it was concluded that the particle size of polylysine precipitated nanogels have a
wider size distribution of 300-500nm whereas particles synthesized using the lyophilization
protocol have a size ranging from 50nm -100nm. Nanogels synthesized from polylysine protocol
have a tendency to aggregate rapidly as seen from DLS studies and TEM studies. Although
macromolecules can be easily encapsulated inside these nanogels, they rapidly diffuse out of the
seemingly porous matrix of these particles. In comparison nanogels synthesized using
Lyophilization protocol are much more stable with regard to aggregation and shows greater
colloidal stability (indicated by the zeta potential of -30mV) as well as better encapsulation
(entrapment inside the matrix) of macromolecules. Proteins such as Hb do not diffuse out of the
sol-gel matrix under most working/biologically relevant conditions. In spite of being confined to
the sol-gel matrix the protein remains active and functional (as shown from studies described in
later chapters). Moreover the degradation of the sol-gel matrix at alkaline conditions can be
further evaluated for potential therapeutic advantage for delivery of encapsulated molecules for
various applications.
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Synthesis of nanogels using different precipitating agents
Synthesis of silica nanoparticles utilizing cationic precipitating peptides such as R5 isolated from
Diatoms have been studied earlier [6,8] and showed potential for development for various
applications. We explored this biomimetic approach, using the polycationic silica precipitating
agent Polylysine and then expanded it to other cationic agents such as Lysine, Arginine and
Histidine. All the nanoparticles were synthesized using the standard polycationic peptide
protocol using equivalent concentrations of precipitating peptides (10mg/ml). The resultant
nanogels size was determined using DLS measurements (Brookhaven Instruments Corporation
BIC) and TEM micrographs (JEOL, model JEM-1200 EX).
Results
The resulting sol-gel based nanoparticles using Lysine gave a smaller average size of 100-300
nm as compared to a larger size of 300-500 nm when using PLL based nanogels. Particles
produced using Arginine have similar size distribution to that of Lysine (100-300 nm), yet
display a lower colloidal stability and low uniformity with high aggregation tendencies. The use
of Histidine for silica precipitation did not provide any defined shapes and showed high
aggregation tendencies (Table 6 and Figure 14).
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Table 6. Differences between nanogels synthesized from different precipitating agents

Precipitating agent

Observation

Polylysine

Circular uniformly dispersed nanogels.
Size: 300-500 nm.

Lysine

Circular shape. Smaller in size as compared to Polylysine.
Size: 100-300 nm. Aggregates readily. Low colloidal stability.

Arginine

Not as uniformly circular, smaller in size as compared to
Polylysine. Size: 100-300 nm. Aggregates readily. Low colloidal
stability.

Histidine

No defined shapes formed. High aggregation.

2µm
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b

a

c

2 µm

500 nm

Figure 14. a. Nanoparticles made by polylysine
Average Size: 400nm, Scale Bar: 500 nm; b.
Nanoparticles made by Lysine, Average Size: 100nm,
Scale Bar: 2µm; c. Nanoparticles made by Arginine,
Average Size: 100nm -300 nm, Scale Bar: 500 nm.
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Conclusions
Precipitation of nanogels using cationic peptides other than polylysine resulted in smaller sizes
(arginine and lysine), although over long periods of time they show low colloidal stability.
Monomeric cationic amino acids are able to produce particles and offer an economic advantage
over longer chain polypeptides. Use of arginine and poly-arginine as precipitating agents is of
much interest as this approach may offer a potential therapeutic advantage due to polyarginine’s
well-known cell penetrating properties for drug delivery [11-14].
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CHAPTER 4
SURFACE MODIFICATION AND PEG DECORATION OF
NANOGELS
In various studies it has been sometimes found that, after synthesizing nanoparticles, aggregation
among particles took place when they were re-suspended in an aqueous solution, because the
suspended silica particles formed agglomerates, probably due to (interparticle) hydrogen bonding
[15]. Steric hindrances, by the use of polymers (steric stabilizers) adsorbed or grafted onto
particle surfaces, have been one answer to the problems posed by aggregations among particles
in an aqueous suspension. In this case, direct contacts among particles are prevented by the
polymer chains extending into the medium. Therefore, aggregation of particles will not be
formed, or the rate of coagulation will be decreased, depending on the degree of coverage of
polymers on the particles and the thickness of the polymer layer [16-18]. We have used
polyethylene glycol (PEG) to coat our nanogels (Figure 15). PEG acts as a steric stabilizer, its
polymeric polyethylene chains extend far into the surrounding medium. Thus, in an aqueous
suspension, the aggregation among the nanoparticles is prevented by the repulsion force and
solvation layer of the PEG surface moiety [19]. Some other important advantages of having PEG
coatings on the silica nanoparticles are due to their applications inside biological samples. PEG
is nontoxic, and its attachment to silica nanoparticles provides a biocompatible and protective
surface [20]. Also, the PEG coatings reduce protein and cell adsorption onto the particles and can
reduce the rate of clearance of PEG coated materials, hence increasing the particle circulation
time in bodily fluids for in vivo applications [21].
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PEG

Figure 15. General structure of Polyethylene Glycol (PEG).

PROCEDURE
Synthesis of PEG coated nanogels
TMOS was hydrolyzed by adding 2mM HCl (2:1 ratio) and sonicated for 30 minutes. Desired
concentration of PEG 400 was added to 50mM phosphate buffer pH 7. The buffer/PEG mixture
was added to the hydrolyzed TMOS (1:1 ratio) and mixed. The solution formed uniform gels in
30 seconds to 1 minute. The casted gel was washed with buffer 3 times.

To make nanogels, the sol-gel films were slightly crushed using a spatula and dried at room
temperature for 12 hours and lyophilized for 5 hours (LABCONCO, freezone).

Dynamic Light Scattering and Zeta Potential Analysis
DLS measurements were performed on a 90 plus particle size analyzer (Brookhaven Instruments
Corporation) employing a 90° scattering angle and a 35 mW incident laser (658 nm). Small
amounts of nanogels (1-2mg) were suspended in deionized water and sonicated for 15 minutes
before taking measurements. The reported diameter is the average of 5 runs for each sample.
Zeta Potential measurements were done by adding small amount (1-2mg) of nanogels in 1mM
KCl solution and sonication for 15 minutes. (Brookhaven Instruments Inc. Zeta Plus).
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Transmission Electron Microscope Studies
Dilute samples used for DLS measurements were mixed in a 1:1 ratio with 1% uranyl acetate,
sonicated for 10 minutes. Then 5ul was put on a carbon film coated copper grid, 300 mesh
(electron microscopy sciences, Hatfield, PA) and the excess solution was removed immediately
using absorbent paper. The grids were dried overnight and viewed under the transmission
electron microscope (JEOL, model JEM-1200 EX). Images were taken with a SIA–L3C CCD
camera (Scientific Instruments and Applications, Inc.) using the software Maxim DL5
(Diffraction Limited, Ottawa, Canada).

Fourier Transform Infrared Spectroscopy (FTIR) Studies
Evidence of the PEG coating was given by FTIR spectra of the dried nanogel particles, recorded
by a FTIR-8400S Shimadzu. The samples were prepared by mixing the pure PEG polymers or
nanogels with KBr by grinding, and then placed some of the powder mixture into a metal mount
to form a pellet in the mount by applying pressure to both ends. The prepared mount was then
placed into the FTIR system, for analysis.

Rhodamine-PEG binding tests using UV Visible Spectroscopy
Control nanogels were prepared using standard Lyophilization protocol (given in Chapter 2).
Synthesized control nanogels were incubated in a solution of Rhodamine-PEG 5000 (Nanocs
Inc.). The nanogels were spun down using a centrifuge at periodic intervals and UV Visible
spectra of the supernatant was taken using Shimadzu UV-2450.
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Results - PEG incorporation within nanogels.
a

Pure nanogels

c 1% PEG 400
modified nanogels

e 5% PEG 400
modified nanogels

b Pure PEG 400

d 2.5% PEG 400
modified nanogels

f 10 % PEG 400
modified nanogels

Figure 16. FTIR spectra of a. pure sol-gel nanoparticles, b. pure PEG 400, c. sol-gel nanoparticles modified
with 1% v/v PEG 400, d. sol-gel nanoparticles modified with 2.5% PEG 400, e. sol-gel nanoparticles with 5%
PEG 400, f. sol-gel nanoparticles with 10% PEG 400. The spectrum of PEGylated sol-gel nanoparticles shows
a new absorption peak at 2882 cm-1, corresponding to one of the characteristic peaks of PEG 400. These peaks
suggest the binding of PEG to the silica particles.
-1

Pure silica particles possess characteristic peaks at 796, 950, 1065, 1400, 1633, and 3400 cm .
Most of the peaks associated with PEG are obscured by overlapping peaks of the pure silica
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nanoparticles. However the spectrum of PEGylated sol-gel nanoparticles (Fig. 16(c-f)) shows a
-1

new absorption peak at 2882 cm , corresponding to one of the characteristic peaks of PEG 400.
These peaks suggest the binding of PEG to the silica particles.

a

b

1µm

1µm

Figure 17. TEM micrographs of a. aggregated nanogels (no PEG) which were stored for 2 days,
Scale Bar: 1µm; b. nanogels with PEG incorporated inside which were stored for 2 days, Scale
Bar: 1µm.

TEM micrographs showed that the PEG encapsulated nanoparticles are more stable over time.
After storage for 2 days without disturbance the particles with PEG were more uniformly
distributed and disaggregated as compared to nanogels without PEG (Figure 17).
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PEG Binding Tests
The binding of PEG to the surface of nanogels was investigated by incubating control nanogels
with a solution of Rhodamine-PEG 5000 adduct (Nanocs inc). (Illustration shown below).
Rhodamine-PEG 5000 adduct solution was incubated with nanoparticles for 2 hours and the
solution was centrifuged away from the nanogel particles and the O.D of the supernatant (at
characteristic wavelength of 558 nm) taken at different time intervals was measured (Figure 18).

Separate supernatant and
measure in UV/Vis
spectrophotometer

Centrifuge

Nanogel pellet left at the
bottom with attached
Rhodamine PEG

Figure 18. Rhodamine-PEG 5000 adduct solution was incubated with nanoparticles for 2 hours and the solution
was centrifuged away from the nanogel particles. Pictures of a. nanogel with Rhodamine PEG 5000 adduct
mixed in the buffer; b. spun down nanogels incubated with Rhodamine PEG 5000 adduct for 2 hours.
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Figure 19. UV/Vis spectra of supernatant from Rhodamine-PEG nanogels.
Rhodamine-PEG adduct solution was incubated with nanogels for 2 hours
and the solution was centrifuged away from the nanogel particles and the
O.D of the supernatant (at characteristic wavelength of 558nm) taken at
different time intervals was measured. After continuous washing
approximately 50% of the PEG-Rhodamine adduct is still bound to the
surface of nanogels indicating that PEG gets adsorbed to the surface of the
nanogels.

As seen in Figure 19, the decrease in O.D at 558nm shows that approx. 50% of the RhodaminePEG adduct was bound to the surface of the particles after 2 hours. After continuous washing the
PEG Rhodamine adduct is still bound to the surface of nanogels indicating that PEG gets
adsorbed to the surface of the nanogels.

PEG binding tests using Sol-Gel Blocks
Sol-gel blocks were made by mixing hydrolyzed TMOS (with 2mM HCl) and 50mM pH 7
phosphate buffer using standard protocol. The gels were molded in glass vials, washed 3 times
with buffer and allowed to stand for 12 hours to age. Equivalent concentrations of Rhodamine B
and Rhodamine- PEG adducts were added to the top surface of two separate sol-gel blocks and
diffusion of added solutions into the gel was observed periodically over a period of 2 hours.
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a

b

Rhodamine

II
I
Control sol-gel blocks with buffer on top
I

c

d
Rhodamine

I

Rhodamine –
PEG adduct

Rhodamine
I

Rhodamine –
PEG adduct

II
Rhodamine –
PEG adduct
II

II

e

I
Rhodamine

II
RhodaminePEG adduct

Figure 20. a. pure sol-gel with buffer; b. sol-gel with Rhodamine dye and Rhodamine PEG-5000 mixed in the
buffer; c. sol-gel after 2 hours d. sol -gel after 2 hours inverted view; e. sol-gel after 2 hours slanted view. After
2 hours of incubation of sol-gel blocks I and II with Rhodamine dye and Rhodamine–PEG adduct respectively,
Rhodamine dye almost completely diffuses inside the sol-gel whereas the Rhodamine-PEG adduct stays mostly
at the surface of the sol-gel.
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As can be seen in Figure 20, after 2 hours of incubation of sol-gel blocks I and II with
Rhodamine dye and Rhodamine–PEG adduct respectively, Rhodamine dye almost completely
diffuses inside the sol-gel whereas the Rhodamine-PEG adduct stays mostly at the surface of the
sol-gel. The Rhodamine PEG adduct is also not seen in the buffer on top of the sol-gel, as
compared to the Rhodamine dye which is evenly distributed throughout the sol-gel and the buffer
on top of it. This indicates that PEG binds to the surface of sol-gel and does not diffuse inside.
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SURFACE MODIFICATION OF NANOGELS USING PHOSPHONATE AND AMINE
GROUPS.
Surface modification of nanogels was done to reduce aggregation of particles and to also provide
linking groups on the surface of the nanogels for attachment of different therapeutic ligands.
When amine and phosphonate groups are present on the surface of particles there is an
elimination of back bonding due to interactions between the amine and phosphonate groups on
the particle surface, thus increasing the shear plane and electrostatic repulsion of the particles.
Amine groups can be attached using 3-Amino propyl triethoxy silane (APTES) and phosphonate
groups by using 3 -(trihydroxysilyl) propyl methyl phosphonate (THPMP) (Figure 21) [22].

Figure 21. a. Attachment of APTES; b. Attachment of APTES and THPMP to nanogels. When amine and
phosphonate groups are present on the surface of particles there is an elimination of back bonding due to
interactions between the amine and phosphonate groups on the particle surface, thus increasing the shear
plane and electrostatic repulsion of the particles [Bagwe et al., 2006].
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Procedure
A mixture of APTES, THPMP and TMOS in ethanol was sonicated for 20 minutes. The resulting
hydrolyzed TMOS solution containing the different organosilane groups was mixed with 50mM
pH 7 phosphate buffer in a 1:1 ratio. This solution gelled within 1 minute. The resulting sol-gel
was dried for 24 hours and lyophilized for 5 hours resulting in modified nanogels (Figure 22).
The modified nanogels were tested for size (DLS) and zeta potential to evaluate their colloidal
stability.

Figure 22. Synthesis of APTES
and THPMP modified nanogels.
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Results
The size of particles as seen from the DLS measurements (Figure 23) increased with increasing
concentrations of amine groups (APTES) and decreased with increasing concentrations of
phosphonate groups (THPMP).
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Figure 23. Effect of increasing amine and phosphonate modification on particle diameter of nanogels. The
size of particles as seen from the DLS measurements increased with increasing concentrations of amine
groups (APTES) and decreased with increasing concentrations of phosphonate groups (THPMP).
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The zeta potential of the particles increases and becomes less negative with increasing amine
concentration (APTES) showing less colloidal stability. On the other hand the zeta potential
becomes increasingly negative with increase in phosphonate concentration (THPMP) suggesting
higher colloidal stability (Figure 24).
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-15
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Figure 24. Effect of increasing amine and phosphonate modification on zeta potential of nanogels. The zeta
potential of the particles increases and becomes less negative with increasing amine concentration (APTES)
showing less colloidal stability. Zeta potential becomes increasingly negative with increase in phosphonate
concentration (THPMP) suggesting higher colloidal stability.
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Conclusions
Our studies on surface modification of nanogels using linkers like PEG, APTES and THPMP
suggest that the surface of particles can be modified to improve the properties of these nanogels
such as aggregation, and linkage to other groups to improve targeting. Furthermore these
modifications can be performed using mild approaches (room temperature and physiological pH)
so as not to affect the nature of the encapsulated molecules.
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CHAPTER 5
SOL-GEL AND NANOGEL ENCAPSULATION OF
MACROMOLECULES
Biological agents can be incorporated inside the sol-gel network and nanogels due to its unique
favorable properties towards proteins and enzymes. Here we have incorporated different
macromolecules inside the sol-gel and nanogel matrices and tested if the proteins are intact and
functional.
Incorporation of Hemoglobin inside sol-gels and nanogels.
Hemoglobin (Hb) is an iron-containing oxygen-transport metalloprotein in the red blood cells of
most vertebrates as well as the tissues of some invertebrates. Hemoglobin in the blood carries
oxygen from the respiratory organs (lungs or gills) to the rest of the body (i.e. the tissues) where
it releases the oxygen for providing energy to power the functions of the organism in the process
called metabolism [23,24].
In most vertebrates, the hemoglobin molecule is an assembly of four globular protein subunits.
Each subunit is composed of a protein chain tightly associated with a non-protein heme group
(Figure 25). A heme group consists of an iron (Fe) ion held in a heterocyclic ring, known as a
porphyrin.
In adult humans, the most common hemoglobin type is a tetramer (which contains 4 subunit
proteins) called hemoglobin A (Figure 25), consisting of two α and two β subunits noncovalently bound, each made of 141 and 146 amino acid residues, respectively. This is denoted
as α2β2. The subunits are structurally similar and about the same size. Each subunit has a
molecular weight of about 16,000 Daltons, for a total molecular weight of the tetramer of about
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64,000 Daltons. Hemoglobin A is the most intensively studied of the hemoglobin molecules [2426].

a

b

Figure 25. a. Structure of human hemoglobin. The proteins' α and β subunits are in red
and blue, and the iron-containing heme groups in green; b. Structure of Heme b group.

The iron ion may be either in the Fe2+ or in the Fe3+ state, but ferrihemoglobin (methemoglobin)
(Fe3+) cannot bind oxygen. While binding, oxygen temporarily and reversibly oxidizes (Fe2+) to
(Fe3+), oxygen temporarily turns into superoxide, thus iron must exist in the +2 oxidation state to
bind oxygen. If superoxide ion associated to Fe3+ is protonated, the hemoglobin iron will remain
oxidized and incapable of binding oxygen. In such cases, the enzyme methemoglobin reductase
will be able to eventually reactivate methemoglobin by reducing the iron center.
It is known that methemoglobin (iron is in 3+, ferric state) absorbs at 405nm. In this state the
hemoglobin cannot bind oxygen. Deoxyhemoglobin (+2 ferrous state) absorbs at 430 nm, this is
not bound to oxygen but it can when exposed to oxygen. Oxyhemoglobin (+2 ferrous state)
absorbs at 415nm. This is when Hb is bound to oxygen. Hemoglobin can shift between different
ligation and oxidation states depending on the environment it is exposed to and this property is
vital for it to perform its function in the body [25-27].
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In this study Met-Hemoglobin was incorporated inside nanogels and sol-gel films using the
standard protocol for nanogels and sol-gel synthesis. To these nanogels and sol-gel films and
nanogels, sodium dithionite (DTT) (a reducing agent) was added to change the oxidation state
and further the nanogels were exposed to oxygen to change the ligation state.
The position of the absorbance peak due to the HEME changes under different ligation states and
oxidation states showing that the protein is functional inside the nanogels and the sol- gel film
(Figure 26). It is seen that encapsulated Met-Hb starts out with an absorbance peak at 405nm,
which shifts to 430 nm after addition of DTT (which changes iron from +3 to +2 oxidation state).
Upon exposure to oxygen the peak returns to 415nm indicating the binding of oxygen and
conversion to oxy-hemoglobin.
These results also show that the diffusion into the sol-gel is very efficient and that water and
added small molecules (such as DTT) can reach the encapsulated protein.

51

Figure 26. UV/Vis spectra of Hemoglobin in solution, encapsulated inside sol-gel films, and
nanogels. It is seen that encapsulated Met-Hb starts out with an absorbance peak at 405nm, which
shifts to 430 nm after addition of dithionite (which changes iron from +3 to +2 oxidation state).
Upon exposure to oxygen the peak returns to 415 nm indicating the binding of oxygen and
conversion to oxy-hemoglobin. The position of the absorbance peak due to the HEME changes
under different ligation states and oxidation states showing that the protein is functional inside the
nanogels and the sol-gel film.
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Incorporation of Glucose Oxidase
The glucose oxidase enzyme (GOx) is an oxido-reductase that catalyzes the oxidation of glucose
to hydrogen peroxide (H2O2) and D-glucono-δ-lactone [28,29].
β-d-glucose + O

Glucose Oxidase
2

hydrogen peroxide + d-glucono-β-lactone

In cells, it helps in breaking sugar down into its metabolites. Glucose oxidase (often extracted
from Aspergillus niger) is widely used for the determination of free glucose in body fluids
(diagnostics), in vegetal raw material, and in the food industry. It also has many applications in
biotechnology, typically enzyme assays for biochemistry including biosensors in nanotechnology
[28-31].
GOx was incorporated inside the nanogels using our standard protocol for synthesis of nanogels
(Figure 27).

TMOS soln.
(2mM HCl + TMOS)

50 mM Phosphate
Buffer pH 7 + GOx

Sol-Gel containing
GOx
Dried and
Lyophilized for 5hrs
GOx encapsulated
nanogels.
Figure 27. Synthesis of GOx encapsulated nanogels
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The presence of GOx inside the sol-gel film was confirmed by checking characteristic
protein UV/Vis peak at 280nm (Figure 28).
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Figure 28. UV/Vis spectra of Glucose Oxidase nanogels. The spectra shows characteristic protein
peak at 280 nm suggesting that the GOx was encapsulated inside the nanogels.

The activity of GOx encapsulated inside the synthesized nanogels was tested by exposing the
nanogels to glucose and using an iodide assay for determination of H2O2 (measured
spectroscopically at 352nm).

The sample containing hydrogen peroxide was mixed with Reagent A (6.5 g KI and 0.5 g
NaOH and 0.05 g ammonium molybdate in 250 mL water, final pH 11) and Reagent B (5 g
biphthalate in 250 mL water, the pH should be 4) in a 1:5:5 ratio. The mixture was allowed to
develop color for 5 minutes before taking UV/Visible Spectra.
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Our studies have showed that GOx when encapsulated inside the sol-gel matrix is functionally
active and is able to generate H2O2 when it is exposed to 0.3 M glucose (Figure 29).
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Figure 29. Continuous release of H2O2 from GOx encapsulated nanogels when
exposed to 0.3 M Glucose. The nanogels were exposed to bathing buffer containing
glucose. The concentration of H2O2 was determined by using an iodide assay for
determination of H2O2 (measured spectroscopically at 352 nm). The rate of formation
of H2O2 is 23.5 µM/min.

When the release rates of nanogels and sol-gel films were compared to that in solution with
equivalent final concentrations of GOx (Figure 30), it was seen that GOx nanogels had the
lowest rate with 18.6 µM/min and the sol-gel films had a slightly higher H2O2 release rate of
23.1 µM/min. The rate in solution is highest (37.9 uM/min) when compared to both nanogels
and sol-gels. The observation may be attributed to the fact that it takes more time for the
dextrose to diffuse into the sol-gel and nanogels and react with the entrapped enzyme and
there is also a delay in the release of H2O2 produced as a result of the reaction.
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Figure 30. Comparison of H2O2 release from nanogels, sol-gel films and solution. All
three samples were exposed to equivalent concentrations of glucose and H2O2
generation was measured using an iodide assay for determination of H 2O2 (measured
spectroscopically at 352nm).

Both the sol-gel and nanogels were actively producing H2O2 after a week of storage.
These results indicate that the sol-gel and nanogel network is capable of holding the protein
intact inside without adversely affecting its biological function.

Sol-gel Incorporation of Transferrin
Transferrins are iron-binding blood plasma glycoproteins that control the level of free iron in
biological fluids. Transferrin glycoproteins bind iron very tightly, but reversibly. Transferrin
has a molecular weight of around 80 KDa and contains two specific high-affinity Fe(III)
binding sites [32]. The affinity of transferrin for Fe(III) is extremely high at pH 7.4 but
decreases progressively with decreasing pH below neutrality. When not bound to iron, it is
known as "apotransferrin" [33].

Transferrin has various roles in diseases and is therefore of great interest to scientists for
therapeutic purposes. An increased plasma transferrin level is often seen in patients suffering
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from iron deficiency anemia. A decreased plasma transferrin can occur in iron overload
diseases and protein malnutrition. An absence of transferrin results from a rare genetic
disorder known as atransferrinemia; a condition characterized by anemia and hemosiderosis
in the heart and liver that leads to many complications, including heart failure [34-36].
Transferrin is also associated with the innate immune system. It is found in the mucosa and
binds iron, thus creating an environment low in free iron that impedes bacterial survival in a
process called iron withholding. The level of transferrin decreases in inflammation [37].
Most recently, transferrin and its receptor have been shown to diminish tumour cells by using
the receptor to attract antibodies [35, 38-40].

We have incorporated Transferrin inside sol-gel films and tested its function and stability
utilizing a Phenanthroline assay for iron determination. 1, 10-Phenanthroline reacts with Fe2+
to form a characteristic orange-colored complex (Figure 31). The intensity of color
development is directly proportional to the amount of Fe2+ in the sample which can be
measured at 510 nm.

3 phen + Fe

2+

----------------> Fe(phen)3

2+

2+

Figure 31. Chemical reaction of 1, 10-Phenanthroline used for iron determination. Ferrous ions
react with 1, 10 Phenanthroline to form an orange colored complex with a characteristic OD at
510 nm.
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Procedure

Transferrin encapsulated sol-gel films were prepared using the standard protocol for sol-gel
films. The films were exposed to 50 mM pH 3 citric acid-phosphate buffer for 1 day. The
bathing buffer was separated and mixed with 10% v/v Hydroxylamine HCl and 0.3% w/v 1,
10 Phenanthroline in 5:1:1 ratio. Hydroxylamine serves to reduce the ferric ion to ferrous ion
which can then react with 1,10 Phenanthroline and form the colored complex. The solution
was allowed to mix for 5 minutes and the O.D at 510 nm was measured using a diode array
UV Visible spectrophotometer (Agilent) (Figure 32).

Figure 32. Phenanthroline assay for iron release test. The sol-gel film encapsulating the apotransferrin was bathed
with 50mM pH 3 buffer. The bathing buffer was separated and mixed with 10% v/v Hydroxylamine HCl and 0.3%
w/v 1, 10 Phenanthroline in 5:1:1 ratio. Hydroxylamine serves to reduce the ferric ion to ferrous ion which can then
react with 1,10 Phenanthroline and form the colored complex. The solution was allowed to mix for 5 minutes and
the OD at 510 nm was measured using a diode array UV -Visible spectrophotometer.

The results showed that the iron held by the transferrin encapsulated inside the sol-gel is released
after exposure to low pH indicating that the transferrin is functionally active even after
entrapment inside the sol-gel matrix (Figure 33).
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Figure 33. The release of iron from transferrin encapsulated inside sol-gel film when exposed to low pH, tested by
Phenanthroline assay using spectroscopic measurement at 510nm.

A similar experiment was done with nanogels incorporated with transferrin. In a period of 2
hours of exposure to low pH almost all the iron was released from the transferrin entrapped
inside the nanogels (Figure 34).

59

Iron Release from transferrin encapsulated inside
Nanogels
0.7

Control

0.6

O.D

0.5
Holotransferrin
(1.6mg/ml)

0.4
0.3
0.2

Bathing buffer
separated from
nanogels after 2
hours

0.1
0
350

400

450

500

550

600

Wavelength (nm)

Figure 34. The release of iron from transferrin encapsulated inside nanogels when exposed to low pH,
tested by Phenanthroline assay using spectroscopic measurement at 510 nm.

Compatibility of transferrin with the sol-gel matrix is promising because transferrin can be used
in drug delivery as a conjugation linker to stabilize and improve the pharmacokinetics of certain
therapeutically-important biomolecules. It efficiently transports these biomolecules and links
with key cell receptors, providing intracellular delivery. Use of Transferrin with biodegradable
nanoparticles such as ours gives rise to possibilities for various therapeutic applications
exploiting the unique advantages of nanogels.
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Conclusions

Fabrication of nanogels with macromolecules encapsulated within was achieved. There was no
significant difference of nanogel properties with or without the encapsulated proteins. In spite of
being confined to the sol-gel matrix, incorporated proteins are active and functional. Their small
molecule substrate and products however can diffuse in and out of the sol-gel matrix. These
results suggest that nanogels are an optimal choice for a macromolecule carrier matrix.
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CHAPTER 6
SOL-GEL AND NANOGEL ENCAPSULATION OF SMALL
MOLECULES
Application of various nanoparticles for the delivery of small therapeutic agents is still being
explored by scientists and a lot of work needs to be done in the characterization and safety of
nanoparticles being studied. Nanogels are suitable carriers for delivery of small molecules due to
their properties. We have synthesized small molecule encapsulated nanogels by utilizing a very
simple technique of trapping the drugs inside the nanogel network while the particles are being
synthesized. The solgel network is able to encapsulate various kinds of drugs such as Ampicllin,
Kanamycin, Thyoquinone and Distamycin A (Figure 35). Our release studies have shown that
drugs are diffused out of the nanogel pores readily because of their small size.
a

c

b

d

Figure 35. Structure of a. Ampicllin, b. Kanamycin, c. Thymoquinone, d. Distamycin A.
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Bacterial cell survival studies were performed using the synthesized antibiotic encapsulated
nanogels using the following procedure.
Procedure for Bacterial Cell survival studies
E. coli was grown aerobically at 37°C for 12-16 h with shaking (250 rpm) in Luria-Bertani
medium (LB). The saturated cultures were diluted in fresh LB medium starting at (OD 600 ) 0.05
(optical density) and incubated at 37 °C in Erlenmeyer flasks with vigorous shaking at 250 rpm
as well until they reached a concentration of 2x 105 cells/ml. Each E.coli solution was incubated
with different nanogels for a total time of 90 minutes. Four dilutions were made at each time
interval and three 20 ul drops were plated from each dilution on solid agar plates. Plates were
incubated overnight at 37o C and colonies counted. All results were compared to the control
without any nanogels (Figure 36).
For each time
point the
concentration
of cells was
determined by
taking a sample
of known
volume from
the original
inoculum and
preparing serial
dilutions.

=

D

n
Number of colonies (n) plate x reciprocal of dilution of sample (1/D) = number of bacteria /ml
in the reaction mixture for a given time point.
Figure 36. Illustration for bacterial cell survival studies of nanogels. An original inoculum of bacteria is
incubated with samples being tested. For each time point the concentration of cells is determined by taking a
sample of known volume from the original inoculum and preparing serial dilutions at different time points
and plating for kinetic study. Number of bacteria at a given time point is calculated by multiplying no. of
surviving colonies on plates by the reciprocal of dilution of samples.
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Synthesis of Kanamycin Encapsulated nanogels and testing on E.coli.
Kanamycin is an aminoglycoside bactericidal antibiotic isolated from the bacterium
Streptomyces kanamyceticus, and is used to treat a wide variety of infections [41].
Kanamycin interacts with the 30S subunit of prokaryotic ribosomes. It induces substantial
amounts of mistranslation and indirectly inhibits translocation during protein synthesis [42, 43].
We have incorporated Kanamycin inside nanogels and tested their effect on E.coli bacterial cells.
The following method was used to prepare Kanamycin encapsulated nanogels:
TMOS (sigma > 99%) was hydrolyzed using 2mM HCl for 30 minutes (2TMOS: 1HCl).
Kanamycin sulfate (Gibco) was mixed in potassium phosphate buffer pH 7, 50mM. This solution
was added to the hydrolyzed TMOS solution (1:1 ratio). This resulted in sol-gel blocks and
Kanamycin was incorporated inside the sol-gel matrix during gelation. The sol-gels produced
were dried at room temperature for 12 hours, slightly crushed using a spatula and lyophilized for
5 hours. (LABCONCO Free Zone 2.5).
Equivalent amounts of control and kanamycin nanogels were taken to test in bacteria. Final
concentration of Kanamycin in the samples tested was 50ug/ml.
As seen in Figure 37, Control nanogels do not have adverse effects on the growth of bacteria,
and Kanamycin encapsulated nanogels are able to deliver the antibiotic to the bacterial cells and
demonstrate rapid killing.
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Figure 37. Effect of Kanamycin encapsulated nanogels on E.coli cell survival. Control nanogels do not have adverse
effects on the growth of bacteria, and Kanamycin encapsulated nanogels are able to deliver the antibiotic to the
bacterial cells and demonstrate rapid killing.

Synthesis of Thymoquinone (TQ) encapsulated nanogels and testing on E.Coli
Thymoquinone is a phytochemical compound found in the plant Nigella sativa. It is known to
exhibit antioxidant, anti-inflammatory and anti- cancer effects and has been shown to protect
against heart, liver and kidney damage in animal studies [44-46]. It has been shown to suppress
the proliferation of various tumor cells, including colorectal carcinoma, breast adenocarcinoma,
osteosarcoma, ovarian carcinoma, myeloblastic leukemia, and pancreatic carcinoma [47–52],
while being minimally toxic to normal cells [53].
Most drugs, especially those with hydrophobic nature such as Thymoquinone, when examined in
human clinical trials fail because of either lack of safety or due to poor efficacy which could be
in part due to poor bioavailability. Although a lot of natural products have served as leads for the
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majority of drugs, poor oral bioavailability has hindered their development without a suitable
carrier [54].
Encapsulation of such a molecule would enhance cytotoxicity based on developments in drug
delivery and nanotechnology.
We describe the design of biodegradable TQ encapsulated nanogels and characterize its effects
on bacterial cell survival. We found that our sol-gel based technique and nontoxic synthesis
method is compatible with a hydrophobic drug such as TQ, moreover TQ encapsulated nanogels
are able to show antibacterial effect on E.coli cells. Successful results from these initial
experiments opens ways for development of other hydrophobic plant based drugs using this
technique.
Procedure
TMOS (sigma > 99%) was hydrolyzed using 2mM HCl for 40 minutes, 2TMOS : 1HCl.
Thymoquinone (Sigma Aldrich) was mixed in potassium phosphate buffer pH 7 50mM. This
solution was added to the hydrolyzed TMOS solution (1:1 ratio) resulting in a sol-gel blocks.
Thymoquinone was incorporated inside the sol-gel matrix during gelation. The sol-gels produced
were dried at room temperature for 12 hours, slightly crushed using a spatula and lyophilized for
5 hours (LABCONCO Free Zone 2.5).
The encapsulation of Thymoquinone was tested by measuring the UV/Vis absorbance of
synthesized nanoparticles at characteristic wavelength of 258nm (Figure 38). Characteristic
peak at 258nm confirmed the encapsulation of Thymoquinone inside the nanogels. The
encapsulation is not 100% efficient, possibly due to the hydrophobic nature of the encapsulated
drug, a portion of the drug may have released during washings of the nanogels.
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Figure 38. UV/Vis spectra of Thymoquinone encapsulated nanogels. Characteristic peak at 258 nm confirmed
the encapsulation of Thymoquinone inside the nanogels.
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Equivalent amounts of control and Thymoquinone nanogels were taken to test in bacteria. Final
conc. of Thymoquinone was 1mg/ml.
As can be seen in Figure 39, the Thymoquinone encapsulated nanogels are able to show killing
towards E.coli, and the control nanogels do not affect the growth of bacteria showing that the
carrier itself is non-toxic to the microorganism.
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Figure 39. Effect of Thymoquinone encapsulated nanogels on bacterial cell survival. Thymoquinone encapsulated
nanogels are able to show killing towards E.coli, and the control nanogels do not affect the growth of bacteria.
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Synthesis of Ampicillin encapsulated nanogels and testing on E.coli.
Ampicillin is an antibiotic useful for the treatment of a number of bacterial infections. It is a
beta-lactam antibiotic that is part of the aminopenicillin family. Ampicillin has been used
extensively to treat bacterial infections since 1961. Until the introduction of ampicillin by the
British company Beecham, penicillin therapies had only been effective against Gram-positive
organisms such as staphylococci and streptococci. Ampicillin also demonstrated activity against
Gram-negative organisms such as H. influenzae, coliforms and Proteus spp. [55,56].
Ampicillin is able to penetrate Gram-positive and some Gram-negative bacteria. It differs from
penicillin G, or benzylpenicillin, only by the presence of an amino group. That amino group
helps the drug penetrate the outer membrane of Gram-negative bacteria [57].
Ampicillin acts as an irreversible inhibitor of the enzyme transpeptidase, which is needed by
bacteria to make their cell walls. It inhibits the third and final stage of bacterial cell wall
synthesis in binary fission, which ultimately leads to cell lysis [57-59].
Since the antibacterial properties of Ampicillin are very well known we have used the antibiotic
to test the effect of our nanogels using E.coli bacterial cells.
Ampicillin encapsulated nanogels were synthesized using the following procedure:
TMOS (sigma > 99%) was hydrolyzed using 2mM HCl for 40 minutes, 2TMOS: 1HCl.
Ampicillin (Gibco) was mixed in potassium phosphate buffer pH 7 50mM. This solution was
added to the hydrolyzed TMOS solution (1:1 ratio) resulting in a sol-gel blocks. Ampicillin was
incorporated inside the sol-gel matrix during gelation. The sol-gels produced were dried at room
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temperature for 12 hours, slightly crushed using a spatula and lyophilized for 5 hours.
(LABCONCO Free Zone 2.5).
Equivalent amounts of control and ampicillin nanogels were taken to test in bacteria. Final conc.
of ampicillin was 100ug/ml.
The bacterial studies (Figure 40) demonstrated the cytotoxicity of the ampicillin encapsulated
towards E.coli cells.
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Figure 40. Effect of Ampicillin encapsulated nanogels on E.coli cell survival. Ampicillin encapsulated nanogels are
able to show killing towards E.coli, and the control nanogels do not affect the growth of bacteria.

Incorporation of Distamycin A in Sol-gel and Nanogels
Distamycin A is an antibiotic produced by Streptomyces distallicus the structure of which was
identified and confirmed by total synthesis by Arcamone et al. (1964). Partially purified
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preparations of Distamycin A exerted an inhibitory action on the development of experimental
tumors. The purified crystalline antibiotic shows antiviral activity on vaccinia and herpes
simplex viruses in vitro or in experimental infections [60-64].
Distamycin A encapsulated nanogels were synthesized using the following method:
TMOS (sigma > 99%) was hydrolyzed using 2mM HCl for 40 minutes, 2TMOS:1HCl.
Distamycin A (Sigma Aldrich) was mixed in potassium phosphate buffer pH 7 50mM. This
solution was added to the hydrolyzed TMOS solution (1:1 ratio) resulting in a sol-gel block.
Distamycin A was incorporated inside the sol-gel matrix during gelation. The sol-gels produced
were dried at room temperature for 12 hours, slightly crushed using a spatula and lyophilized for
5 hours. (LABCONCO Free Zone 2.5) (Figure 41).

Sol -Gel containing
Distamycin A

Dried and
Lyophilized for5
hours

Nanogels with
Distamycin A
Figure 41. Illustration of synthesis of Distamycin A encapsulated nanogels.
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The incorporation of Distamycin A inside the nanogels was tested by suspending the nanogels in
buffer and checking the characteristic UV/ Visible absorbance of Distamycin at 303 nm
(Figure 42). It was seen that Distamycin A was successfully encapsulated inside the nanogels.
Distamycin A being a small molecule readily diffuses out of the nanogels (described in Chapter
3). Nevertheless these studies indicate compatibility of various small molecules with nanogels
which show promise for further development.

0.8

Distamycin in solution
Distamycin in Nanogel

Absorbance

0.6

303 nm

0.4

0.2

200

250

300
350
Wavelength (nm)

400

450

Figure 42. UV/Vis Spectra of Distamycin A encapsulated nanogels. The spectra shows peak at
characteristic wavelength 303 nm indicating encapsulation of Distamycin A inside nanogels.
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SILVER NANOPARTICLE –SOL-GEL HYDRID NANOGELS
Resistance of bacteria to bactericides and antibiotics has increased in recent years due to the
development of resistant strains. Some antimicrobial agents are extremely irritant and toxic and
there is much interest in finding ways to formulate new types of safe and cost-effective biocidal
materials. Previous studies have shown that antimicrobial formulations in the form of
nanoparticles could be used as effective bactericidal materials. It has been demonstrated that
highly reactive metal oxide nanoparticles exhibit excellent biocidal action against Gram-positive
and Gram-negative bacteria [65]. Thus, the synthesis and characterization of inorganic particles
opens the possibility of formulation of a new generation of bactericidal materials. Various
studies have indicated that silver ions and silver-based compounds are highly toxic to
microorganisms showing strong biocidal effects on as many as 16 species of bacteria including
E. coli [65-70]. Thus, silver ions, as an antibacterial component, have been used for various
applications such as dental resin composites and ion exchange fibers and in coatings of medical
devices [70-73]. The antibacterial activity of silver ions is well known and has been studied in
detail. In 2004 Sondi and group have investigated the antibacterial activity of nontoxic
elementary silver, in the form of nanoparticles and demonstrated the toxicity of silver towards
bacteria [66].
In an effort to prepare a novel safe and nontoxic silver carrier, we have synthesized and
characterized hybrid nanogels by incorporating silver nanoparticles inside sol-gel based
nanoparticles.
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PROCEDURE
Synthesis of Silver Nanoparticles
The solution containing Silver Nanoparticles was prepared in two steps. First 45mg of silver
nitrate (AgNO3) was dissolved in 250mL of deionized water and heated slowly until the solution
reached to 95-98 °C. In the second step, a 5ml of 1% (w/w) sodium citrate solution was made
and added to the heated silver nitrate solution. This mixture was kept between 95 to 98 °C for an
hour and product formation was evident when the mixture’s color changed to dark yellowgreenish. After about 1 hour the solution was cooled slowly to room temperature.

Synthesis of Silver nps –Sol-gel Hybrid nanogels
Silver nanoparticle solution was mixed with 50mM pH 7 phosphate buffer in a 1:1 ratio. This
mixture was added to hydrolyzed TMOS solution (1:1 ratio). After mixing uniformly the solution
formed a sol-gel within 2 minutes. The film was dried at room temperature for 12 hours crushed
and lyophilized for 5 hours resulting in hybrid nanogels (Figure 43).
SOL-GEL

LYOPHILIZATION

SILVER NANOPARTICLES

ENCAPSULATION OF SILVER
NANOPARTICLES WITHIN
NANOGELS

Figure 43. Illustration for Synthesis of Silver nanoparticle - sol-gel hybrid nanogels.
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The synthesized nanogels were characterized using Dynamic Light Scattering, UV/Visible
Spectroscopy and Transmission Electron Microscopy.

Table 7. Effective Diameter and Zeta Potential of Synthesized Hybrid nanogels as characterized using DLS studies.
Encapsulation of silver nanoparticles inside the nanogels does not affect the original particle size and colloidal
stability of the nanogels.

Sample
Silver Nanoparticles

Effective Diameter (nm)
50

Zeta Potential (mV)
-50

Sol-gel nanoparticles (nanogels)

360

-30

Silver Nanoparticles encapsulated in
nanogels (Hybrid nanogels)

370

-30

Silver nanoparticles as seen from TEM and DLS studies are about 50nm in size, they have good
colloidal stability with a zeta potential of -50 mV. Encapsulation of silver nanoparticles inside
the nanogels does not affect the original particle size and colloidal stability of the nanogels (as
seen from the almost similar effective diameter and zeta potential values) (Table 7).
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The incorporation of silver nanoparticles inside the nanogel matrix was confirmed by UV/Visible
spectroscopy of hybrid nanogels which shows characteristic peak of silver nanoparticles at
420nm (Figure 44).
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Figure 44. The figure compares UV/Vis spectra of the hybrid nanogels (blue
trace); of control nanogels that do not contain silver nanoparticles (red trace) and
of the bathing buffer in which the hybrid nanogels were incubated for 24 hours
and then separated (black trace).
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Conclusions
Various antibiotics were encapsulated inside the nanogels and tested on E.coli. The synthesized
nanogels were able to kill bacterial cells indicating that encapsulated antibiotics are able to
diffuse out from the nanogel matrix in a sustained manner and show therapeutic effect. Control
nanogels without any antibiotic show no toxicity towards bacteria confirming the nontoxic
properties of nanogel matrix offering a huge advantage as a carrier.
Silver nanoparticles were encapsulated inside the nanogels resulting in hybrid nanogels which
are stable and intact and do not change the properties of the nanogel matrix.
Silver nanoparticles are known to have great potential for applications such as biosensors,
biological tags for quantitative detection. They also have antibacterial applications and have been
incorporated in apparel, footwear, paints, wound dressings, appliances, cosmetics, and plastics.
Hybrid nanogels can provide additional benefits by acting as a nontoxic, inert carrier with
sustained release from porous sol-gel matrix. Properties of sol-gel such as PEG binding,
nonimmunogenic, surface decoration can be utilized if needed.
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CHAPTER 7
H2O2 AND NO DELIVERY USING NANOGELS
A cell survival study on E.coli
Nitric oxide (NO) is a short-lived, diatomic, lipophilic gas that plays an integral role in
defending against pathogens. NO regulates a range of biological processes in the cardiovascular,
gastrointestinal, genitourinary, respiratory, and central and peripheral nervous systems [74, 75].
Among its many functions are involvement in immune cell signaling and in the biochemical
reactions by which immune cells defend against bacteria, fungi, viruses and parasites. NO
signaling directs a broad spectrum of processes, including the differentiation, proliferation, and
apoptosis of immune cells. Furthermore, the discoveries of NO as a vasodilator, antibacterial
agent, and tumoricidal factor have made NO a promising pharmaceutical agent [74-78]. These
observations led to the need for NO delivery systems that can harness its antimicrobial
properties. A number of synthetic compounds that chemically store and release NO in a
controlled fashion have been developed. Several classes of NO donors exist including
nitrosothiols, nitrosamines, diazeniumdiolates, NO-metal complexes, and organic nitrites and
nitrates [78,79].
Sodium Nitroprusside (SNP) is one such NO donor. Nitroprusside is a complex anion that
features an octahedral ferrous center surrounded by five tightly bound cyanide ligands and one
linear nitric oxide ligand (Figure 45). SNP when exposed to light generates NO [79-82]. Since
the sol-gel is a glass like transparent substance it is apt for encapsulation of photosensitive
materials which can then be controlled to generate desired products.
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Figure 45. Structure of Sodium Nitroprusside (SNP).

The glucose oxidase enzyme (GOx) is an oxido-reductase that catalyzes the oxidation of
glucose to hydrogen peroxide and D-glucono-δ-lactone. In cells, it helps in breaking sugar down
into its metabolites. GOx (often extracted from Aspergillus niger) is widely used for the
determination of free glucose in body fluids (diagnostics), in vegetal raw material, and in the
food industry. It also has many applications in biotechnology, typically enzyme assays for
biochemistry including biosensors in nanotechnology [28].

Our studies have showed (Chapter 5) that GOx when encapsulated inside the sol-gel
matrix is functionally active and is able to generate H2O2 when glucose is provided. The
antimicrobial properties of H2O2 have been studied in depth and are well known. Previous
studies by some groups and experiments done by us have demonstrated that Nitric oxide
potentiates hydrogen peroxide-induced killing of Escherichia coli [83, 84] (Figure 46). For
prokaryotes subjected to oxidative injury, NO was found to enhance the bactericidal effect of
H2O2, lending support to the concept that NO plays a critical role in host defense against
invading pathogens. It has also been demonstrated in our studies that the presence of cyclic
nitroxide antioxidants such as TEMPOL (4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxyl)
(Figure 46,47) protect the cells from the synergic killing effect [83].
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Figure 46. E.coli cell survival studies showing the synergistic activity of NO and H2O2 in solution. H2O2 alone
shows some killing, however NO markedly potentiates H2O2-induced killing of E. coli. The antioxidant TEMPOL
abrogates the synergic killing effect of NO and H2O2.

TEMPOL

Figure 47. Structure of the antioxidant 4hydroxy-2,2,6,6-tetramethylpiperidin-1oxyl (TEMPOL).
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Based on our previous experiments the suggested mechanism for the NO and H2O2
synergic killing effect is described below.
A main route for H2O2 toxicity is through the formation of OH radicals (Hydroxyl
radicals). This reaction is very slow but is catalyzed by iron, through the Haber-Weiss reaction.
(See scheme below). In the cells, nitric oxide can release Iron ions from bacterial [4Fe-4S]
protein clusters storage, thereby providing the catalyst for the Haber-Weiss reaction, forming OH
radicals and resulting in a synergic killing effect. Moreover, nitroxides such as TEMPOL can
effectively oxidize cellular redox-active metals and pre-empt the Fenton reaction explaining the
abrogation of the synergic killing effect in the presence of TEMPOL [83].

The Haber-Weiss Catalytic Cycle:
Step I. Reduction of ferric ion to ferrous ion
Fe3+ + •O2- → Fe2+ + O2
Step II: The Fenton Reaction
Fe2+ + H2O2 → Fe3+ + OH- + •OH
Net reaction:
•O2- + H2O2 → •OH + OH- + O2

Combination of H2O2 and NO is highly toxic to prokaryotes and has potential in
antimicrobial therapy. However maintaining a constant H2O2 concentration for treatment
becomes complicated because microorganisms have their own biological mechanisms for
removal of H2O2 (using cellular catalases and peroxidases). To overcome this problem a
sustained release of H2O2 and NO is required for treatment which will be able to continuously
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deliver the drugs to the bacterial cells. We have synthesized antibacterial, NO and H2O2
generating nanogel delivery systems, by encapsulating the enzyme glucose oxidase (GOx) and
the NO donor SNP inside the nanogels. These nanogels when exposed to dextrose and light will
generate H2O2 and NO simultaneously in a controlled manner (Figure 48). We have also
demonstrated that TEMPOL encapsulated nanogels protect bacterial cells from synergic killing
by H2O2/NO combination.

Herein, we report a biocompatible mild synthetic approach to

preparing NO and H2O2 generating nanogels which have the potential to act as treatment for
combination therapy for multidrug resistant bacteria.
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Figure 48. Illustration shows a combination of
GOx and SNP nanogels, which when exposed
to Glucose and Light generate NO and H2O2
which are released into the surrounding
solution.
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Procedure
Synthesis of NO generating nanogels.
TMOS (sigma > 99%) was hydrolyzed using 2mM HCl for 30 minutes (Bransonic). Potassium
Phosphate Buffer pH 7 50mM (with desired SNP concentration) was added to the hydrolyzed
TMOS solution (1:1 ratio). SNP was incorporated inside the sol-gel matrix during gelation. The
sol-gels produced were dried at room temperature for 12 hours, slightly crushed using a spatula
and lyophilized for 5 hours (LABCONCO Free Zone 2.5).

Synthesis of H2O2 generating nanogels.
TMOS (sigma > 99%) was hydrolyzed using 2mM HCl for 30 minutes (Bransonic). Potassium
Phosphate Buffer pH 7 50mM (with desired GOx concentration) was added to the hydrolyzed
TMOS solution (1:1 ratio). GOx was incorporated inside the sol-gel matrix during gelation. The
sol-gels produced were dried at room temperature for 12 hours, slightly crushed using a spatula
and lyophilized for 5 hours. (LABCONCO Free Zone 2.5)

Generation of H2O2 and NO from nanogels.
The generation of H2O2 was measured using an iodide assay and UV/Visible spectroscopy
(absorbance at 352 nm). The generation of NO was indirectly measured by nitrite determination
using griess’s reagent. (Absorbance at 540nm) (thermo scientific nanodrop2000).
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Dynamic Light Scattering and Zeta Potential Analysis
DLS measurements were performed on a 90 plus particle size analyzer (Brookhaven Instruments
Corporation) employing a 90° scattering angle and a 35 mW incident laser (658 nm). Small
amounts of nanogels (1-2mg) were suspended in deionized water and sonicated for 15 minutes
before taking measurements. The reported diameter is the average of 5 runs for each sample.
Zeta Potential measurements were done by adding small amount (1-2mg) of nanogels in 1mM
KCl solution and sonication for 15 minutes (Brookhaven Instruments Inc. Zeta Plus).
Transmission Electron Microscope (TEM) Studies
Dilute samples used for DLS measurements were mixed in a 1:1 ratio with 1% uranyl acetate,
sonicated for 10 minutes. Then 5ul was put on a carbon film coated copper grid, 300 mesh
(electron microscopy sciences, Hatfield, PA) and the excess solution was removed immediately
using absorbent paper. The grids were dried overnight and viewed under the transmission
electron microscope (JEOL, model JEM-1200 EX). Images were taken with a SIA–L3C CCD
camera (Scientific Instruments and Applications, Inc.) using the software Maxim DL5
(Diffraction Limited, Ottawa, Canada).
E.coli experiments
E. coli was grown aerobically at 37°C for 12-16 h with shaking (250 rpm) in Luria-Bertani
medium (LB). The saturated cultures were diluted in fresh LB medium starting at (OD 600) 0.05
(optical density) and incubated at 37 °C in Erlenmeyer flasks with vigorous shaking at 250 rpm
as well until they reached a concentration of 2x105 cells/ml. Each E.coli solution was incubated
with different nanogels for a total time of 90 minutes. All samples were exposed to light and
dextrose at time 0. Catalase (10U/ml) was added to remove residual H2O2 and terminate the
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oxidative stress. Four dilutions were made at each time interval and three 20 ul drops were plated
from each dilution on solid agar plates. Plates were incubated overnight at 37oC and colonies
counted. All results were compared to the control without any nanogels.
Results
DLS measurements showed that the effective diameter of the particles produced was between
100-500 nm (Table 8). GOx and SNP nanogels are also colloidally stable as seen by the zeta
potential of -35 and -31mV respectively (Table 9).

Table 8. Size of GOx and SNP nanogels as measured by Dynamic Light Scattering.

Sample
Control nanogels
GOx encapsulated nanogels
SNP nanogels

Effective Diameter (nm)
(from DLS)
428
294
259

Size (nm)
(from TEM)
60-100
20-100
20-100

Table 9. Zeta Potential of GOx and SNP nanogels as measured by the Zeta Analyzer.

Sample
Control nanogels
GOx encapsulated nanogels
SNP nanogels

Zeta Potential (mV)
-30
-35
-31
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Transmission electron micrographs show (Figure 49) that the nanogels are circular, well
distributed particles in the size range of 20-100nm.

a

0.5 um

b

0.5 um

Figure 49. TEM micrographs of a. SNP encapsulated
nanogels, Scale Bar: 0.5µm; b. GOx encapsulated nanogels,
Scale Bar: 0.5 µm. The average size of the nanogels for both
samples range from 20-100nm.
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GOx and SNP were successfully incorporated inside the nanogels. As tested by UV visible
spectroscopy it was seen that the GOx is not only successfully encapsulated within the sol-gel
matrix, but is also functional as it is able to generate hydrogen peroxide upon addition of glucose
to the nanogel solution. The generation of H2O2 was spectrophotometrically measured using an
iodide assay (wavelength 352nm) (Figure 50a). When the nanogels are suspended in a solution
of glucose, the glucose molecules are able to travel inside the porous matrix and react with the
enzyme to generate H2O2, which is released out into the solution.
Similarly, SNP encapsulated nanogels when exposed to light generate NO (NO is quickly
converted to nitrite which can be measured by griess’s reagent at wavelength 540nm) (Figure
50b).
2.5

[H2O2] (mM)

2.0
1.5
1.0
0.5
0.0
0

50
Time (min)

100

50
Time (min)

100

[Nitrite] (uM)

200
150
100
50
0
0

Figure 50. a. Generation of H2O2 from GOx encapsulated nanogels upon exposure to glucose. The concentration
of H2O2 at each time point was determined using an iodide assay (352nm); b. Generation of Nitrite from SNP
encapsulated nanogels upon exposure to light. The concentration of Nitrite at each time point was determined
using Griess reagent (540nm).
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Generation of H2O2 and NO from nanogels synthesized using Lyophilization protocol.
H2O2 and NO generating nanogels were tested on cell survival of bacteria. During the
experiments there was continuous monitoring of the concentrations of H2O2 and NO
concentration using the iodide assay and Griess reagent respectively.

The results demonstrated that GOx nanogels are able to show killing towards E.coli. Moreover
the combination of GOx nanogels and SNP nanogels show much higher killing rate as compared
to GOx alone. This effect is due to the H2O2/NO release combination (Figure 51). Using
nanogels we were able to demonstrate the same effect as seen in solution indicating that nanogels
are simultaneously able to deliver H2O2 and NO.

When the GOx and SNP is encapsulated inside the same nanogels, the same combination of
H2O2/NO toxicity is seen again (Figure 52). These results show the superior property of
nanogels as a hybrid or multipurpose carrier.
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Figure 51. a. Growth curves of E.Coli when incubated with different nanogels. GOx nanogels are able
to show killing towards E.coli. Moreover the combination of GOx nanogels and SNP nanogels show
much higher killing rate as compared to GOx alone. This effect is due to the H 2O2/NO release
combination; b. Concentration of nitrite as a function of time during the experiment (measured using
Griess reagent); c. Concentration of H2O2 generated as a function of time during the experiment
(measured using iodide assay).
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Figure 52. Growth curves of E.Coli when incubated with hybrid nanogels containing all the chemicals in one
nanogel matrix. When the GOx and SNP is encapsulated inside the same nanogels, the same combination
H2O2/NO toxicity is seen again.
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It was seen in solution experiments that TEMPOL is capable of protecting the bacterial cells
from the H2O2/NO synergistic killing. When TEMPOL encapsulated nanogels are added to the
combinations of GOx ngs and SNP ngs, the TEMPOL is able to diffuse put and protect the cells
from killing (Figure 53).
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Figure 53. E.coli cell survival study showing protection of E.coli cells from H2O2/NO toxicity by TEMPOL
encapsulated nanogels.

Generation of H2O2 and NO from nanogels synthesized using Polylysine protocol.
Generation of H2O2 and NO was also achieved using nanogels produced using the Polycationic
peptides. The nanogels were able to continuously generate H2O2 and NO and were able to show
killing towards E.coli cells (Figure 54).
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Figure 54. a. Growth curves of E.Coli when incubated with H2O2 generating nanogels synthesized using the
polylysine protocol, SNP was added externally; b. Concentration of nitrite as a function of time during the
experiment (measured using Griess reagent); c. Concentration of H2O2 generated as a function of time during
the experiment (measured using Iodide assay).
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Nanogels synthesized using both protocols (Lyophilization and Polylysine protocol) displayed
similar results. When E.Coli was incubated with GOx encapsulated nanogels, the growth curves
showed substantial killing of the bacteria over time as compared to control bacteria, which was
correlated to the H2O2 generated from the GOx nanogels (measured simultaneously). Moreover a
combination of GOx encapsulated nanogels and SNP encapsulated nanogels displayed enhanced
killing of the bacteria due to the potentiating effect of the NO released towards the killing effect
of H2O2.

Conclusions
This study shows that enzymes and small molecules co-encapsulated inside the nanogel matrix
are capable of carrying out multiple reactions and generate products in a sustained manner. We
were able to reproduce results from H2O2/NO synergy solution studies inside nanogels. The
H2O2 and NO generating nanogels that were studied here displayed good antibacterial activity
against E.coli. This work integrates nanotechnology and bacteriology, leading to possible
advances in the formulation of new types of bactericides. However, future studies on the biocidal
influence of this nanomaterial on other Gram positive and Gram-negative bacteria are necessary
in order to fully evaluate its possible use as a new bactericidal material.
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CHAPTER 8
OUTLOOK
Important Features of Sol- Gel Based Nanoparticles
One of the most useful properties of sol-gel based nanoparticles is easy and mild synthetic
technique. There is minimal effect of the silicate matrix on the properties of encapsulated
therapeutic molecules and macromolecules and they remain effective and functional. Successful
co-encapsulation of different biologically active agents can be achieved for multi targeted
therapy. Our studies have shown sustained delivery of sol-gel co-encapsulation of therapeutic
agents to bacterial cells. Moreover the nanogels in themselves exhibited a very low toxicity
towards bacteria. All these properties are highly desirable in a carrier matrix for therapeutic
agents and show promise for further development.

Future Development
We have in this work developed recipes to easily synthesize nanogels and have characterized
some aspects of these particles that will be useful for further development of them as therapeutic
carriers. There are still interesting questions which are worthwhile to explore, and further
developments are necessary. It would also be interesting to conduct studies to find different silica
precipitating agents to improve biomimetic methods for production of non-toxic and inert
nanoparticles. Further investigations into effect of these nanogels on different kinds of
microorganisms would be useful for advancement of such nanoparticles for antimicrobial
therapy. Although there have been some studies on intake of silicate nanoparticles by
mammalian cells, interactions between nanogels and cells are not fully understood and need
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further probing. Studies in mammalian cell cultures are needed. Assessment of bio-distribution
and blood circulation levels and interaction with serum proteins need to be studied in detail and
testing in animal models is required for further development of nanogels for therapeutic
purposes.

Potential Applications
Nanogels offer potential for various kinds of interesting applications which we came across as
we developed methods to synthesize and characterize them. An important application is
Multidrug

resistance

antibiotic

therapy

for

infections

such

as

Methicillin-resistant

Staphylococcus aureus (MRSA). Combination therapy using various antibiotic agents would be
compatible with the nanogel carrier as shown in our studies. Since the nanogel matrix can hold
proteins intact and unharmed, it has potential to be used in diagnostics and biosensor fields.
Further developments into surface modification of the nanogels would also enable them to be
used as inert, nontoxic agents for potential antitumor therapy.
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ABBREVIATIONS
APTES
DLS
DTT
FTIR
GOx
Hb
Mb
ngs
NO
nps
PEG
PLL
SNP
Soln.
TEM
TEMPOL
Tf
THPMP
TMOS
TQ
UV/Vis

3- Amino propyl triethoxy silane
Dynamic Light Scattering
Sodium Dithionite
Fourier Transform Infrared spectroscopy
Glucose Oxidase
Hemoglobin
Myoglobin
Nanogels
Nitric Oxide
Nanoparticles
Polyethylene glycol
Poly-L-Lysine
Sodium Nitroprusside
solution
Transmission Electron Microscopy
4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxyl
Transferrin
3-(trihydroxysilyl) propyl methyl phosphonate
Tetra methyl orthosilicate
Thymoquinone
UV visible spectroscopy
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